Clin2
NCT04613921Possibly a fitRecruiting

Liver transplant study for severe worsening liver failure

Liver DiseasesLiver CirrhosisAcute-On-Chronic Liver FailureLiver Transplant; Complications

Part of Digestive system clinical trials.

This study looks at when liver transplant is offered and what outcomes happen in people with cirrhosis who have severe “acute-on-chronic” worsening. It may help doctors decide which patients benefit most from transplant and improve care after listing or not listing.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
3,000 people
Ages
18 years to 80 years
Study type
Observational

Who can take part

  • You’re 18 years or older.
  • You have been diagnosed with cirrhosis (scarring of the liver).
  • You were hospitalized because your cirrhosis suddenly got worse and you were referred to a transplant team.
  • Your case fits one of these transplant situations: listed with severe acute-on-chronic liver failure, or listed with advanced poor liver function, or being assessed but not ultimately listed.
  • You (or a trusted person if you can’t speak for yourself) can give informed consent.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06142968Not yet recruiting
Liver failure study in cirrhosis patients

This study looks at patients with cirrhosis who are admitted to the intensive care unit with acute-on-chronic liver failure. It aims to understand and improve care for this serious condition using a standard scoring system.

NCT05951231Not yet recruiting
Liver transplant using a donor liver kept alive outside the body

This trial studies whether using an “ex vivo perfusion” process—keeping a donor liver alive outside the body before transplant—can improve outcomes for certain people who need a liver transplant but have limited options. It may help patients who are too high-risk for standard transplant timing or options, including some cancer-related liver disease cases.

NCT07131540Not yet recruiting· Phase 1
Stem cell therapy for severe liver failure (Phase 1 safety study)

This early-phase study tests whether stem cells (called mesenchymal stem cells) are safe and can help people with a sudden, severe liver failure. You may qualify if your liver is failing quickly and you are not eligible for a transplant.

NCT03946852Not yet recruiting
Testing a new blood-boost method for liver transplants after cardiac death

This study tests whether a special way of moving blood through the donor abdomen before surgery can improve liver (and other organ) transplant quality. It may help because doctors can check how well the liver seems to be working before it’s actually used.

NCT02038517Recruiting
Liver transplant waitlist study for people without diabetes

This study is for people with end-stage cirrhosis who are on the liver transplant waitlist at this hospital. It aims to understand how getting a liver transplant may affect people with and without diabetes-related issues.

Milan, MI
NCT07777705Not yet recruiting
Predicting liver transplant outcomes with scoring tools

This study uses different scoring systems to predict how well patients with cirrhosis will do while waiting for a liver transplant. It helps doctors understand which patients are most likely to benefit from the transplant.

Hear when a new Liver Diseases trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.